Literature DB >> 19760221

Prognostic value of CD208-positive cell infiltration in gastric cancer.

Sumiya Ishigami1, Shinichi Ueno, Masataka Matsumoto, Hiroshi Okumura, Takaaki Arigami, Yasuto Uchikado, Tetsuro Setoyama, Hideo Arima, Ken Sasaki, Masaki Kitazono, Hiroyuki Shinchi, Yuko Kijima, Shoji Natsugoe.   

Abstract

BACKGROUND AND AIM: A new marker, CD208, was recently explored as a mature interdigitating dendritic cell (DC), and the correlation between the infiltration of CD208-positive cells and clinical factors has been reported in various types of cancers. In this study, we tried to clarify the clinical implication of CD208-positive cell infiltration in gastric cancer immunohistochemically. PATIENTS AND METHODS: A total of 128 gastric cancer patients who underwent a curative operation were enrolled. DCs in tumor nests were identified with two DC markers, CD208 and S-100 protein (S100), by immunohistochemistry. The correlation between clinicopathological features and the CD208- or S100-positive cell infiltration degree was analyzed.
RESULTS: Infiltration of S100-positive cells did not correlate with the degree of CD208-positive cell infiltration. Patients with high CD208-positive cell infiltration in the peritumor had a poorer surgical outcome than those with low CD208 infiltration (p < 0.05). Multivariate analysis revealed that CD208-positive cell infiltration was not an independent prognostic factor.
CONCLUSION: We showed that intratumoral CD208-positive cells, as mature DCs, had an inverse correlation to patients' postoperative outcome in gastric cancer, unlike a conventional DC marker. Evaluation of CD208-positive cell infiltration with S100-positive cell infiltration in gastric cancer is useful to predict antitumor immunological conditions in gastric cancer.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19760221     DOI: 10.1007/s00262-009-0758-8

Source DB:  PubMed          Journal:  Cancer Immunol Immunother        ISSN: 0340-7004            Impact factor:   6.968


  12 in total

1.  Impact of tumor-infiltrating LAMP-3 dendritic cells on the prognosis of esophageal squamous cell carcinoma.

Authors:  Junya Nishimura; Hiroaki Tanaka; Yoshihito Yamakoshi; Soichiro Hiramatsu; Tatsuro Tamura; Takahiro Toyokawa; Kazuya Muguruma; Kiyoshi Maeda; Kosei Hirakawa; Masaichi Ohira
Journal:  Esophagus       Date:  2019-04-09       Impact factor: 4.230

2.  Role of dendritic cells in progression and clinical outcome of colon cancer.

Authors:  Maya V Gulubova; Julian R Ananiev; Tatyana I Vlaykova; Yovcho Yovchev; Vanya Tsoneva; Irena M Manolova
Journal:  Int J Colorectal Dis       Date:  2011-11-09       Impact factor: 2.571

3.  Tumor infiltration by Tbet+ effector T cells and CD20+ B cells is associated with survival in gastric cancer patients.

Authors:  Audrey Hennequin; Valentin Derangère; Romain Boidot; Lionel Apetoh; Julie Vincent; David Orry; Jean Fraisse; Sylvain Causeret; François Martin; Laurent Arnould; Françoise Beltjens; François Ghiringhelli; Sylvain Ladoire
Journal:  Oncoimmunology       Date:  2015-06-03       Impact factor: 8.110

Review 4.  Trial watch: Dendritic cell-based anticancer therapy.

Authors:  Norma Bloy; Jonathan Pol; Fernando Aranda; Alexander Eggermont; Isabelle Cremer; Wolf Hervé Fridman; Jitka Fučíková; Jérôme Galon; Eric Tartour; Radek Spisek; Madhav V Dhodapkar; Laurence Zitvogel; Guido Kroemer; Lorenzo Galluzzi
Journal:  Oncoimmunology       Date:  2014-12-21       Impact factor: 8.110

Review 5.  Inflammation-related factors predicting prognosis of gastric cancer.

Authors:  Wen-Jun Chang; Yan Du; Xin Zhao; Li-Ye Ma; Guang-Wen Cao
Journal:  World J Gastroenterol       Date:  2014-04-28       Impact factor: 5.742

6.  CD68 and CD83 immune populations in non-metastatic axillary lymph nodes are of prognostic value for the survival and relapse of breast cancer patients.

Authors:  Carlos López; Ramón Bosch; Anna Korzynska; Marcial García-Rojo; Gloria Bueno; Joan Francesc García-Fontgivell; Salomé Martínez González; Andrea Gras Navarro; Esther Sauras Colón; Júlia Casanova Ribes; Lukasz Roszkowiak; Daniel Mata; Meritxell Arenas; Junior Gómez; Albert Roso; Marta Berenguer; Silvia Reverté-Villarroya; Montserrat Llobera; Jordi Baucells; Marylène Lejeune
Journal:  Breast Cancer       Date:  2022-02-08       Impact factor: 4.239

7.  High expression of CD11c indicates favorable prognosis in patients with gastric cancer.

Authors:  Yuan Wang; Bin Xu; Wen-Wei Hu; Lu-Jun Chen; Chang-Ping Wu; Bin-Feng Lu; Yue-Ping Shen; Jing-Ting Jiang
Journal:  World J Gastroenterol       Date:  2015-08-21       Impact factor: 5.742

8.  CD11c-Positive Dendritic Cells in Triple-negative Breast Cancer.

Authors:  Heejae Lee; Hee Jin Lee; In Hye Song; Won Seon Bang; Sun-Hee Heo; Gyungyub Gong; In Ah Park
Journal:  In Vivo       Date:  2018 Nov-Dec       Impact factor: 2.155

9.  Trial watch: Prognostic and predictive value of the immune infiltrate in cancer.

Authors:  Laura Senovilla; Erika Vacchelli; Jerome Galon; Sandy Adjemian; Alexander Eggermont; Wolf Hervé Fridman; Catherine Sautès-Fridman; Yuting Ma; Eric Tartour; Laurence Zitvogel; Guido Kroemer; Lorenzo Galluzzi
Journal:  Oncoimmunology       Date:  2012-11-01       Impact factor: 8.110

10.  Difference in distribution profiles between CD163+ tumor-associated macrophages and S100+ dendritic cells in thymic epithelial tumors.

Authors:  Mutsuko Omatsu; Toshiaki Kunimura; Tetsuya Mikogami; Akira Shiokawa; Tomoko Nagai; Atsuko Masunaga; Akihiko Kitami; Takashi Suzuki; Mitsutaka Kadokura
Journal:  Diagn Pathol       Date:  2014-12-14       Impact factor: 2.644

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.